Coronary inflammation on chest computed tomography and COVID-19 mortality.

Adipose tissue COVID-19 Coronary Hospital mortality Inflammation

Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
15 Jan 2024
Historique:
received: 11 08 2023
accepted: 14 12 2023
revised: 06 12 2023
medline: 15 1 2024
pubmed: 15 1 2024
entrez: 14 1 2024
Statut: aheadofprint

Résumé

The main factors associated with coronavirus disease-19 (COVID-19) mortality are age, comorbidities, pattern of inflammatory response, and SARS-CoV-2 lineage involved in infection. However, the clinical course of the disease is extremely heterogeneous, and reliable biomarkers predicting adverse prognosis are lacking. Our aim was to elucidate the prognostic role of a novel marker of coronary artery disease inflammation, peri-coronary adipose tissue attenuation (PCAT), available from high-resolution chest computed tomography (HRCT) in COVID-19 patients with severe disease requiring hospitalization. Two distinct groups of patients were admitted to Parma University Hospital in Italy with COVID-19 in March 2020 and March 2021 (first- and third-wave peaks of the COVID-19 pandemic in Italy, with the prevalence of wild-type and B.1.1.7 SARS-CoV-2 lineage, respectively) were retrospectively enrolled. The primary endpoint was in-hospital mortality. Demographic, clinical, laboratory, HRCT data, and coronary artery HRCT features (coronary calcium score and PCAT attenuation) were collected to show which variables were associated with mortality. Among the 769 patients enrolled, 555 (72%) were discharged alive, and 214 (28%) died. In multivariable logistic regression analysis age (p < 0.001), number of chronic illnesses (p < 0.001), smoking habit (p = 0.006), P/F ratio (p = 0.001), platelet count (p = 0.002), blood creatinine (p < 0.001), non-invasive mechanical ventilation (p < 0.001), HRCT visual score (p < 0.001), and PCAT (p < 0.001), but not the calcium score, were independently associated with in-hospital mortality. Coronary inflammation, measured with PCAT on non-triggered HRCT, appeared to be independently associated with higher mortality in patients with severe COVID-19, while the pre-existent coronary atherosclerotic burden was not associated with adverse outcomes after adjustment for covariates. The current study demonstrates that a relatively simple measurement, peri-coronary adipose tissue attenuation (PCAT), available ex-post from standard high-resolution computed tomography, is strongly and independently associated with in-hospital mortality. • Coronary inflammation can be measured by the attenuation of peri-coronary adipose tissue (PCAT) on high-resolution CT (HRCT) without contrast media. • PCAT is strongly and independently associated with in-hospital mortality in SARS-CoV-2 patients. • PCAT might be considered an independent prognostic marker in COVID-19 patients if confirmed in other studies.

Identifiants

pubmed: 38221582
doi: 10.1007/s00330-023-10573-8
pii: 10.1007/s00330-023-10573-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to European Society of Radiology.

Références

Grasselli G, Zangrillo A, Zanella A et al (2020) COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. https://doi.org/10.1001/jama.2020.5394
doi: 10.1001/jama.2020.5394 pubmed: 32250385 pmcid: 7136855
Ierardi AM, Gaibazzi N, Tuttolomondo D et al (2021) Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables. Radiol Med. https://doi.org/10.1007/s11547-020-01312-w
doi: 10.1007/s11547-020-01312-w pubmed: 33890201 pmcid: 8050998
Frizzelli A, Tuttolomondo D, Aiello M, Majori M, Bertorelli G, Chetta A (2020) What happens to people’s lungs when they get coronavirus disease 2019? Acta Biomed. https://doi.org/10.23750/abm.v91i2.9574
doi: 10.23750/abm.v91i2.9574 pubmed: 32420938 pmcid: 7569635
Ticinesi A, Nouvenne A, Cerundolo N et al (2021) Trends of COVID-19 admissions in an Italian hub during the pandemic peak: large retrospective study focused on older subjects. J Clin Med. https://doi.org/10.3390/jcm10051115
doi: 10.3390/jcm10051115 pubmed: 33800020 pmcid: 7962097
Istituto Superiore di Sanità. CS N° 20/2021 - Covid-19: in Italia la ‘variante inglese’ all’86,7% Il 4,0% dei casi con quella ‘brasiliana’. Comunicato 30 Mar 2021 (Italian Language). https://www.iss.it/web/guest/primo-piano/-/asset_publisher/3f4alMwzN1Z7/content/id/5683229#:~:text=ISS%2C%2030%20marzo%202021%20%2D%20In,sotto%20lo%200%2C5%25 . Accessed 28 Dec 2023
Dabrera G, Allen H, Zaidi A et al; COG-UK Consortium (2022) Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2022.27.20.2100377
Kyriakopoulos C, Ntritsos G, Gogali A, Milionis H, Evangelou E, Kostikas K (2021) Tocilizumab administration for the treatment of hospitalized patients with COVID-19: a systematic review and meta-analysis. Respirology. https://doi.org/10.1111/resp.14152
doi: 10.1111/resp.14152 pubmed: 34605114 pmcid: 8661720
Ticinesi A, Tuttolomondo D, Nouvenne A et al (2022) Co-administration of remdesivir and azithromycin may protect against intensive care unit admission in COVID-19 pneumonia requiring hospitalization: a real-life observational study. Antibiotics (Basel). https://doi.org/10.3390/antibiotics11070941
doi: 10.3390/antibiotics11070941 pubmed: 35884195
Shoar S, Hosseini F, Naderan M, Mehta JL (2020) Meta-analysis of cardiovascular events and related biomarkers comparing survivors versus non-survivors in patients with COVID-19. Am J Cardiol. https://doi.org/10.1016/j.amjcard.2020.08.044
doi: 10.1016/j.amjcard.2020.08.044 pubmed: 32916148 pmcid: 7477637
Tuttolomondo D, Frizzelli A, Aiello M, Bertorelli G, Majori M, Chetta A (2022) Beyond the lung involvement in COVID-19 patients. Minerva Med. https://doi.org/10.23736/S0026-4806.20.06719-1
doi: 10.23736/S0026-4806.20.06719-1 pubmed: 32567823
Ridker PM, Everett BM, Thuren T et al; CANTOS Trial Group (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. https://doi.org/10.1056/NEJMoa1707914
Tardif JC, Kouz S, Waters DD et al (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. https://doi.org/10.1056/NEJMoa1912388
doi: 10.1056/NEJMoa1912388 pubmed: 31733140
Eberhardt N, Noval MG, Kaur R et al (2023) SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. BioRxiv. https://doi.org/10.1101/2023.08.14.553245
doi: 10.1101/2023.08.14.553245 pubmed: 37645908 pmcid: 10461985
Dias-Neto M, Meekel JP, van Schaik TG et al (2018) High density of periaortic adipose tissue in abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. https://doi.org/10.1016/j.ejvs.2018.07.008
doi: 10.1016/j.ejvs.2018.07.008 pubmed: 30115505
Gaibazzi N, Tuttolomondo D, Nicolini F et al (2021) The histopathological correlate of peri-vascular adipose tissue attenuation on computed tomography in surgical ascending aorta aneurysms: is this a measure of tissue inflammation? Diagnostics (Basel). https://doi.org/10.3390/diagnostics11101799
doi: 10.3390/diagnostics11101799 pubmed: 34829434
Pasqualetto MC, Tuttolomondo D, Cutruzzolà A et al (2021) Human coronary inflammation by computed tomography: relationship with coronary microvascular dysfunction. Int J Cardiol. https://doi.org/10.1016/j.ijcard.2021.05.040
doi: 10.1016/j.ijcard.2021.05.040 pubmed: 34052238
Antonopoulos AS, Sanna F, Sabharwal N et al (2017) Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aal2658
doi: 10.1126/scitranslmed.aal2658 pubmed: 28701474
Oikonomou EK, Marwan M, Desai MY et al (2018) Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. https://doi.org/10.1016/S0140-6736(18)31114-0
doi: 10.1016/S0140-6736(18)31114-0 pubmed: 30170852 pmcid: 6137540
Simpson S, Kay FU, Abbara S et al (2020) Radiological society of north america expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. https://doi.org/10.1148/ryct.2020200152
doi: 10.1148/ryct.2020200152 pubmed: 33778571 pmcid: 7233549
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. https://doi.org/10.1016/0735-1097(90)90282-t
doi: 10.1016/0735-1097(90)90282-t pubmed: 2407762
Kwiecinski J, Dey D, Cadet S et al (2019) Peri-coronary adipose tissue density is associated with
doi: 10.1016/j.jcmg.2018.11.032 pubmed: 31422128 pmcid: 6689460
Gaibazzi N, Martini C, Botti A, Pinazzi A, Bottazzi B, Palumbo AA (2019) Coronary inflammation by computed tomography pericoronary fat attenuation in MINOCA and Tako-Tsubo syndrome. J Am Heart Assoc. https://doi.org/10.1161/JAHA.119.013235
doi: 10.1161/JAHA.119.013235 pubmed: 31462127 pmcid: 6755824
Fisman DN, Tuite AR (2021) Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario. Canada. https://doi.org/10.1503/cmaj.211248
doi: 10.1503/cmaj.211248
Davies NG, Abbott S, Barnard RC et al (2021) Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. https://doi.org/10.1126/science.abg3055
doi: 10.1126/science.abg3055 pubmed: 34941392 pmcid: 8970537
Ticinesi A, Parise A, Nouvenne A et al (2023) Insights from comparison of the clinical presentation and outcomes of patients hospitalized with COVID-19 in an Italian internal medicine ward during first and third wave. Front Med (Lausanne). https://doi.org/10.3389/fmed.2023.1112728
doi: 10.3389/fmed.2023.1112728 pubmed: 36817786
Budoff MJ, Nasir K, Kinney GL et al (2011) Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort. J Cardiovasc Comput Tomogr. https://doi.org/10.1016/j.jcct.2010.11.002
doi: 10.1016/j.jcct.2010.11.002 pubmed: 22146500 pmcid: 3246505
Xie X, Zhao Y, de Bock GH et al (2013) Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: systematic review and meta-analysis. Circ Cardiovasc Imaging. https://doi.org/10.1161/CIRCIMAGING.113.000092
doi: 10.1161/CIRCIMAGING.113.000092 pubmed: 23756678
van Velzen SGM, Lessmann N, Velthuis BK et al (2020) Deep learning for automatic calcium scoring in CT: validation using multiple cardiac CT and chest CT protocols. Radiology. https://doi.org/10.1148/radiol.2020191621
doi: 10.1148/radiol.2020191621 pubmed: 32043947
Almeida S, Pelter M, Shaikh K et al (2020) Feasibility of measuring pericoronary fat from precontrast scans: effect of iodinated contrast on pericoronary fat attenuation. J Cardiovasc Comput Tomogr. https://doi.org/10.1016/j.jcct.2020.04.004
doi: 10.1016/j.jcct.2020.04.004 pubmed: 32576456
Tan N, Dey D, Marwick TH, Nerlekar N (2023) Pericoronary adipose tissue as a marker of cardiovascular risk: JACC Review Topic of the Week. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2022.12.021
doi: 10.1016/j.jacc.2022.12.021 pubmed: 37914512 pmcid: 9983040

Auteurs

Domenico Tuttolomondo (D)

Cardiology Unit, Azienda Ospedaliero-Universitaria di Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.

Andrea Ticinesi (A)

Department of Medicine and Surgery, University of Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.
Geriatric-Rehabilitation Department, Azienda Ospedaliero-Universitaria di Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.

Damini Dey (D)

Cedars-Sinai Medical Center, Biomedical Imaging Research Institute, Los Angeles, CA, USA.

Chiara Martini (C)

Department of Medicine and Surgery, University of Parma, Via Antonio Gramsci 14, 43126, Parma, Italy. MartiniC@ao.pr.it.
Diagnostic Department, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy. MartiniC@ao.pr.it.

Antonio Nouvenne (A)

Geriatric-Rehabilitation Department, Azienda Ospedaliero-Universitaria di Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.

Maria Nicastro (M)

Department of Medicine and Surgery, University of Parma and Unit of Occupational Medicine and Industrial Toxicology, University Hospital of Parma, 43121, Parma, Italy.

Massimo De Filippo (M)

Department of Medicine and Surgery, Section of Radiology, University of Parma, Maggiore Hospital, Via Gramsci 14, 43125, Parma, Italy.

Nicola Sverzellati (N)

Diagnostic Department, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy.

Francesco Nicolini (F)

Department of Cardiac Surgery, Parma University Hospital, Via Gramsci 14, 43126, Parma, Italy.

Tiziana Meschi (T)

Department of Medicine and Surgery, University of Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.
Geriatric-Rehabilitation Department, Azienda Ospedaliero-Universitaria di Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.

Nicola Gaibazzi (N)

Cardiology Unit, Azienda Ospedaliero-Universitaria di Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.

Classifications MeSH